News | April 15, 2025
Biocon Biologics secures market entry date for Yesafili in US
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
The supply of these goods is set to commence within the first quarter of FY26
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
Bloom has pioneered a technology to transform plant waste into valuable chemical products
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Announces Rs. 317 crore investment in new recycling plant
Subscribe To Our Newsletter & Stay Updated
